Self-reported medication and herb/supplement use by women with and without fibromyalgia

Journal of Women's Health

Volumn 18, Issue 5, 2009, Pages 709-716

  Shaver, Joan L ^a   Wilbur, Joellen ^b   Lee, Hyeongkyeong ^c   Robinson, F Patrick ^a   Wang, Edward ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH UNIVERSITY   (United States)

^c Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; FATTY ACID; FATTY ACID DERIVATIVE; FISH OIL; GLUCOSAMINE; GUAIFENESIN; HYPNOTIC AGENT; MUSCLE RELAXANT AGENT; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; ORAL CONTRACEPTIVE AGENT; PREGABALIN; PRIMROSE OIL; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SPASMOLYTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ANALGESIA; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; ECHINACEA; FEMALE; FIBROMYALGIA; GARLIC; GINKGO BILOBA; HERB; HUMAN; LACTOBACILLUS ACIDOPHILUS; MAJOR CLINICAL STUDY; PAIN; PRIORITY JOURNAL; SCORING SYSTEM; SELF REPORT; SOYBEAN; SYMPTOM; TELEPHONE;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIDEPRESSIVE AGENTS; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FEMALE; FIBROMYALGIA; HUMANS; MIDDLE AGED; PHYTOTHERAPY; PLANTS, MEDICINAL; SELF CARE; SELF MEDICATION; SEROTONIN UPTAKE INHIBITORS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 68349156007     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.1194     Document Type: Article

References (21)

1. Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 2000;160: 221-227.
2. Staud R. Biology and therapy of fibromyalgia: Pain in fi-bromyalgia syndrome. Arthritis Res Ther 2006;8:208. (DOI: 10.1186/ar1950)
3. Crofford LJ, Pillemer SR, Kalogeras KT, et al. Hypothalamic-pituitary- adrenal axis perturbations in patients with fi-bromyalgia. Arthritis Rheum 1994;37:1583-1592.
4. Cohen H, Neumann L, Shore M, et al. Autonomic dysfunction in patients with fibromyalgia: Application of power spectral analysis of heart rate variability. Semin Arthritis Rheum 2000;29:217-227.
5. Jones JF, Nisenbaum R, Reeves WC. Medication use by persons with chronic fatigue syndrome: Results of a randomized telephone survey in Wichita, Kansas. Health Qual Life Outcomes 2003;1:74-79.
6. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004;292:2388-2395.
7. Sarac AJ, Gur A. Complementary and alternative medical therapies in fibromyalgia. Curr Pharm Des 2006;12:47-57.
8. Pioro-Boisset M, Esdaile JM, Fitzcharles MA. Alternative medicine use in fibromyalgia syndrome. Arthritis Care Res 1996;9:13-17.
9. Holdcraft LC, Assefi N, Buchwald D. Complementary and alternative medicine in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol 2003;17:667-683.
10. Sim J, Adams N. Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia. Clin J Pain 2002;18:324-336.
11. Merchant RE, Carmack CA, Wise CM. Nutritional supplementation with Chlorella pyrenoidosa for patients with fi-bromyalgia syndrome: A pilot study. Phytother Res 2000;14: 167-173.
12. Merchant RE, Andre C. A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis. Altern Ther 2001;7:79-91.
13. Abraham GE, Flechas ID. Management of fibromyalgia: A rationale for the use of magnesium and malic acid. J Nut Med 1992;3:49-59.
14. Russell IJ, Michalek JE, Flechas JD, et al. Treatment of fi-bromyalgia syndrome with Super Malic: A randomized, double-blind, placebo controlled, crossover pilot study. J Rheumato 1995;22:953-958.
15. Shaver JL, WilburJ,Robinson FP,etal. Women's health issues with fibromyalgia syndrome. J Womens Health 2006;15: 1035-1045.
16. Wahner-Roedler DL, Elkin PL, Vincent A, et al. Use of complementary and alternative medical therapies by patients referred to a fibromyalgia treatment program at a tertiary care center. Mayo Clin Proc 2005;80:55-60.
17. St. Amand RP, Marek C. The use of uricosuric agents in fibromyalgia: Theory, practice and a rebuttal to the Oregon Study of Guaifenesin Treatment. Clin Bull Myofascial Ther 1997;2:5. Available at www.fibromyalgiatreatment. com/ GuaiProtocol.htm Accessed February 6, 2009.
18. Marsden J, Strickland C, Clements TL. Guaifenesin as a treatment for primary dysmenorrhea. J Am Board Fam Phys 2004;4:240-246.
19. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-1273.
20. Mease PJ, Russell IJ, Arnold LM, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregaba-lin in the treatment of patients with fibromyalgia. J Rheumatol 2008;35:502-514.
21. O'Malley PG, Balden E, Tomkins G, et al. Treatment of fi-bromyalgia with antidepressants. A meta-analysis. J Gen Intern Med 2000;15:659-666.